x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 13-1952290 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
100 First Stamford Place, Stamford, CT | 06902 | |
(Address of principal executive offices) | (Zip Code) |
(check one): | ||||||
Large accelerated filer | x | Accelerated filer | o | |||
Non-accelerated filer | o (Do not check if a smaller reporting company) | Smaller reporting company | o |
Three Months Ended | |||||||
March 31, | |||||||
2016 | 2015 | ||||||
Net sales | $ | 660.0 | $ | 678.8 | |||
Operating costs and expenses: | |||||||
Cost of sales | 426.1 | 442.0 | |||||
Selling, general and administrative | 148.8 | 148.6 | |||||
Restructuring (gain) charge | (0.4 | ) | 0.5 | ||||
Acquisition integration related charges | — | 1.6 | |||||
Operating profit | 85.5 | 86.0 | |||||
Other income (expense): | — | ||||||
Interest income | 0.5 | 0.5 | |||||
Interest expense | (9.1 | ) | (9.9 | ) | |||
Miscellaneous - net | (0.3 | ) | (0.3 | ) | |||
(8.9 | ) | (9.7 | ) | ||||
Income before income taxes | 76.6 | 76.3 | |||||
Provision for income taxes | 21.4 | 24.9 | |||||
Net income before allocation to noncontrolling interests | 55.2 | 51.3 | |||||
Less: Noncontrolling interest in subsidiaries’ earnings | 0.2 | 0.3 | |||||
Net income attributable to common shareholders | $ | 55.0 | $ | 51.1 | |||
Earnings per basic share | $ | 0.95 | $ | 0.88 | |||
Earnings per diluted share | $ | 0.93 | $ | 0.87 | |||
Weighted average basic shares outstanding | 58.2 | 58.1 | |||||
Weighted average diluted shares outstanding | 58.9 | 58.9 | |||||
Dividends per share | $ | 0.33 | $ | 0.33 |
Three Months Ended | |||||||
March 31, | |||||||
2016 | 2015 | ||||||
Net income before allocation to noncontrolling interests | $ | 55.2 | $ | 51.3 | |||
Other comprehensive income (loss), net of tax | |||||||
Currency translation adjustment | 31.8 | (70.9 | ) | ||||
Changes in pension and postretirement plan assets and benefit obligation, net of tax | 1.9 | 2.0 | |||||
Other comprehensive income (loss) | 33.7 | (68.9 | ) | ||||
Comprehensive income before allocation to noncontrolling interests | 88.9 | (17.6 | ) | ||||
Less: Noncontrolling interests in comprehensive income (loss) | 0.3 | 0.1 | |||||
Comprehensive income (loss) attributable to common shareholders | $ | 88.6 | $ | (17.7 | ) |
March 31, 2016 | December 31, 2015 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 354.0 | $ | 363.5 | |||
Accounts receivable, net | 430.2 | 397.6 | |||||
Current insurance receivable - asbestos | 20.5 | 20.5 | |||||
Inventories, net: | |||||||
Finished goods | 111.8 | 102.3 | |||||
Finished parts and subassemblies | 51.5 | 46.9 | |||||
Work in process | 72.2 | 60.7 | |||||
Raw materials | 166.4 | 167.0 | |||||
Inventories, net | 401.9 | 376.9 | |||||
Current deferred tax asset | 27.7 | 27.5 | |||||
Other current assets | 20.4 | 17.5 | |||||
Total current assets | 1,254.7 | 1,203.5 | |||||
Property, plant and equipment: | |||||||
Cost | 825.7 | 809.5 | |||||
Less: accumulated depreciation | 545.8 | 533.5 | |||||
Property, plant and equipment, net | 279.9 | 276.0 | |||||
Long-term insurance receivable - asbestos | 105.8 | 108.7 | |||||
Long-term deferred tax assets | 155.9 | 162.4 | |||||
Other assets | 106.1 | 101.3 | |||||
Intangible assets, net | 314.3 | 317.1 | |||||
Goodwill | 1,178.3 | 1,167.9 | |||||
Total assets | $ | 3,395.0 | $ | 3,336.9 |
March 31, 2016 | December 31, 2015 | ||||||
Liabilities and equity | |||||||
Current liabilities: | |||||||
Short-term borrowings | $ | 78.1 | $ | 49.6 | |||
Accounts payable | 199.1 | 223.3 | |||||
Current asbestos liability | 75.0 | 75.0 | |||||
Accrued liabilities | 213.5 | 218.6 | |||||
U.S. and foreign taxes on income | 9.9 | 6.3 | |||||
Total current liabilities | 575.6 | 572.8 | |||||
Long-term debt | 744.8 | 744.6 | |||||
Accrued pension and postretirement benefits | 231.4 | 235.4 | |||||
Long-term deferred tax liability | 52.0 | 50.0 | |||||
Long-term asbestos liability | 456.8 | 470.5 | |||||
Other liabilities | 109.5 | 112.8 | |||||
Total liabilities | 2,170.1 | 2,186.1 | |||||
Commitments and contingencies (Note 8) | |||||||
Equity: | |||||||
Preferred shares, par value $.01; 5,000,000 shares authorized | — | — | |||||
Common stock, par value $1.00; 200,000,000 shares authorized, 72,426,139 shares issued | 72.4 | 72.4 | |||||
Capital surplus | 262.4 | 263.6 | |||||
Retained earnings | 1,710.1 | 1,674.3 | |||||
Accumulated other comprehensive loss | (343.1 | ) | (376.7 | ) | |||
Treasury stock | (488.6 | ) | (494.2 | ) | |||
Total shareholders’ equity | 1,213.2 | 1,139.4 | |||||
Noncontrolling interests | 11.7 | 11.4 | |||||
Total equity | 1,224.9 | 1,150.8 | |||||
Total liabilities and equity | $ | 3,395.0 | $ | 3,336.9 | |||
Common stock issued | 72,426,139 | 72,426,139 | |||||
Less: Common stock held in treasury | (14,130,196 | ) | (14,317,102 | ) | |||
Common stock outstanding | 58,295,943 | 58,109,037 |
Three Months Ended | |||||||
March 31, | |||||||
2016 | 2015 | ||||||
Operating activities: | |||||||
Net income attributable to common shareholders | $ | 55.0 | $ | 51.1 | |||
Noncontrolling interests in subsidiaries’ earnings | 0.2 | 0.3 | |||||
Net income before allocation to noncontrolling interests | 55.2 | 51.3 | |||||
Restructuring - Non Cash | — | 0.2 | |||||
Depreciation and amortization | 16.5 | 16.5 | |||||
Stock-based compensation expense | 6.1 | 5.8 | |||||
Defined benefit plans and postretirement expense | (2.4 | ) | (1.6 | ) | |||
Deferred income taxes | 5.3 | 4.3 | |||||
Cash used for operating working capital | (82.0 | ) | (57.1 | ) | |||
Defined benefit plans and postretirement contributions | (2.2 | ) | (3.0 | ) | |||
Environmental payments, net of reimbursements | (2.0 | ) | (4.1 | ) | |||
Asbestos related payments, net of insurance recoveries | (10.8 | ) | (10.7 | ) | |||
Other | (1.7 | ) | (13.4 | ) | |||
Total used for operating activities | (18.0 | ) | (11.6 | ) | |||
Investing activities: | |||||||
Capital expenditures | (11.0 | ) | (10.2 | ) | |||
Proceeds from disposition of capital assets | 0.5 | 1.4 | |||||
Total used for investing activities | (10.5 | ) | (8.8 | ) | |||
Financing activities: | |||||||
Dividends paid | (19.2 | ) | (19.1 | ) | |||
Reacquisition of shares on open market | — | (25.0 | ) | ||||
Stock options exercised - net of shares reacquired | (1.4 | ) | 6.7 | ||||
Excess tax benefit from stock-based compensation | — | 0.9 | |||||
Repayment of credit facility | — | (100.0 | ) | ||||
Proceeds from issuance of commercial paper | 28.5 | 126.7 | |||||
Total provided by (used for) financing activities | 7.9 | (9.9 | ) | ||||
Effect of exchange rates on cash and cash equivalents | 11.1 | (19.0 | ) | ||||
Decrease in cash and cash equivalents | (9.5 | ) | (49.3 | ) | |||
Cash and cash equivalents at beginning of period | 363.5 | 346.3 | |||||
Cash and cash equivalents at end of period | $ | 354.0 | $ | 296.9 | |||
Detail of cash used for working capital: | |||||||
Accounts receivable | $ | (28.8 | ) | $ | (37.9 | ) | |
Inventories | (21.9 | ) | (20.2 | ) | |||
Other current assets | (2.9 | ) | (4.0 | ) | |||
Accounts payable | (26.4 | ) | (12.7 | ) | |||
Accrued liabilities | (6.9 | ) | 8.5 | ||||
U.S. and foreign taxes on income | 4.9 | 9.2 | |||||
Total | $ | (82.0 | ) | $ | (57.1 | ) | |
Supplemental disclosure of cash flow information: | |||||||
Interest paid | $ | 0.8 | $ | 1.5 | |||
Income taxes paid | $ | 11.5 | $ | 7.7 |
Financial Statement Line | As Previously Reported | Adjustments Debt Issuance Costs | As Revised | ||||||
Other assets | $ | 106.0 | $ | (4.7 | ) | $ | 101.3 | ||
Total assets | 3,341.6 | (4.7 | ) | 3,336.9 | |||||
Long-term debt | 749.3 | (4.7 | ) | 744.6 | |||||
Total liabilities and equity | 3,341.6 | (4.7 | ) | 3,336.9 |
Three Months Ended | ||||||||
March 31, | ||||||||
(in millions) | 2016 | 2015 | ||||||
Net sales | ||||||||
Fluid Handling | $ | 248.0 | $ | 275.5 | ||||
Payment & Merchandising Technologies | 172.0 | 171.9 | ||||||
Aerospace & Electronics | 171.7 | 161.6 | ||||||
Engineered Materials | 68.3 | 69.7 | ||||||
Total | $ | 660.0 | $ | 678.8 | ||||
Operating profit (loss) | ||||||||
Fluid Handling | $ | 25.4 | $ | 34.3 | ||||
Payment & Merchandising Technologies | 28.0 | 21.1 | ||||||
Aerospace & Electronics | 33.1 | 30.1 | ||||||
Engineered Materials | 13.7 | 14.3 | ||||||
Corporate | (14.7 | ) | (13.7 | ) | ||||
Total | 85.5 | 86.0 | ||||||
Interest income | 0.5 | 0.5 | ||||||
Interest expense | (9.1 | ) | (9.9 | ) | ||||
Miscellaneous - net | (0.3 | ) | (0.3 | ) | ||||
Income before income taxes | $ | 76.6 | $ | 76.3 |
As of | |||||||
March 31, | December 31, | ||||||
(in millions) | 2016 | 2015 | |||||
Assets | |||||||
Fluid Handling | $ | 907.7 | $ | 888.0 | |||
Payment & Merchandising Technologies | 1,213.8 | 1,178.0 | |||||
Aerospace & Electronics | 569.4 | 559.4 | |||||
Engineered Materials | 234.0 | 227.6 | |||||
Corporate | 470.1 | 483.9 | |||||
Total | $ | 3,395.0 | $ | 3,336.9 |
As of | |||||||
March 31, | December 31, | ||||||
(in millions) | 2016 | 2015 | |||||
Goodwill | |||||||
Fluid Handling | $ | 221.0 | $ | 218.7 | |||
Payment & Merchandising Technologies | 583.4 | 575.2 | |||||
Aerospace & Electronics | 202.5 | 202.6 | |||||
Engineered Materials | 171.4 | 171.4 | |||||
Total | $ | 1,178.3 | $ | 1,167.9 |
Three Months Ended | ||||||||
March 31, | ||||||||
(in millions) | 2016 | 2015 | ||||||
Fluid Handling | ||||||||
Process Valves and Related Products | $ | 155.0 | $ | 175.7 | ||||
Commercial Valves | 72.4 | 79.6 | ||||||
Other Products | 20.6 | 20.2 | ||||||
Total Fluid Handling | $ | 248.0 | $ | 275.5 | ||||
Payment & Merchandising Technologies | ||||||||
Payment Acceptance and Dispensing Products | $ | 117.7 | $ | 123.9 | ||||
Merchandising Equipment | 54.3 | 48.0 | ||||||
Total Payment & Merchandising Technologies | $ | 172.0 | $ | 171.9 | ||||
Aerospace & Electronics | ||||||||
Commercial Original Equipment | $ | 90.0 | $ | 86.5 | ||||
Military and Other Original Equipment | 40.6 | 33.1 | ||||||
Commercial Aftermarket Products | 30.4 | 31.7 | ||||||
Military Aftermarket Products | 10.7 | 10.3 | ||||||
Total Aerospace & Electronics | $ | 171.7 | $ | 161.6 | ||||
Engineered Materials | ||||||||
FRP - Recreational Vehicles | $ | 35.2 | $ | 38.9 | ||||
FRP - Building Products | 22.5 | 21.2 | ||||||
FRP - Transportation | 10.6 | 9.6 | ||||||
Total Engineered Materials | $ | 68.3 | $ | 69.7 | ||||
Total Net Sales | $ | 660.0 | $ | 678.8 |
Three Months Ended | |||||||
March 31, | |||||||
(in millions, except per share data) | 2016 | 2015 | |||||
Net income attributable to common shareholders | $ | 55.0 | $ | 51.1 | |||
Average basic shares outstanding | 58.2 | 58.1 | |||||
Effect of dilutive stock options | 0.7 | 0.8 | |||||
Average diluted shares outstanding | 58.9 | 58.9 | |||||
Earnings per basic share | $ | 0.95 | $ | 0.88 | |||
Earnings per diluted share | $ | 0.93 | $ | 0.87 |
Three Months Ended March 31, | |||||||||||||||||||||||
2016 | 2015 | ||||||||||||||||||||||
(in millions) | Total Shareholders’ Equity | Noncontrolling Interests | Total Equity | Total Shareholders’ Equity | Noncontrolling Interests | Total Equity | |||||||||||||||||
Balance, beginning of period | $ | 1,139.4 | $ | 11.4 | $ | 1,150.8 | $ | 1,059.8 | $ | 10.8 | $ | 1,070.6 | |||||||||||
Dividends | (19.2 | ) | — | (19.2 | ) | (19.1 | ) | — | (19.1 | ) | |||||||||||||
Reacquisition on open market | — | — | — | (25.0 | ) | — | (25.0 | ) | |||||||||||||||
Exercise of stock options, net of shares reacquired | (1.4 | ) | — | (1.4 | ) | 6.7 | — | 6.7 | |||||||||||||||
Stock compensation expense | 6.1 | — | 6.1 | 5.8 | — | 5.8 | |||||||||||||||||
Excess tax benefit (shortfall) from stock based compensation | (0.3 | ) | — | (0.3 | ) | 0.9 | — | 0.9 | |||||||||||||||
Net income | 55.0 | 0.2 | 55.2 | 51.1 | 0.3 | 51.3 | |||||||||||||||||
Other comprehensive income (loss) | 33.6 | 0.1 | 33.7 | (68.7 | ) | (0.2 | ) | (68.9 | ) | ||||||||||||||
Comprehensive income (loss) | 88.6 | 0.3 | 88.9 | (17.7 | ) | 0.1 | (17.6 | ) | |||||||||||||||
Balance, end of period | $ | 1,213.2 | $ | 11.7 | $ | 1,224.9 | $ | 1,011.4 | $ | 10.9 | $ | 1,022.3 |
(in millions) | Defined Benefit Pension and Other Postretirement Items* | Currency Translation Adjustment | Total | |||||||||
Balance as of December 31, 2015 | $ | (266.2 | ) | $ | (110.6 | ) | $ | (376.7 | ) | |||
Other comprehensive loss before reclassifications | 0.1 | 31.7 | 31.8 | |||||||||
Amounts reclassified from accumulated other comprehensive income | 1.8 | — | 1.8 | |||||||||
Net current-period other comprehensive income (loss) | 1.9 | 31.7 | 33.6 | |||||||||
Balance as of March 31, 2016 | $ | (264.3 | ) | $ | (78.9 | ) | $ | (343.1 | ) |
Details of Accumulated Other Comprehensive Income Components (in millions) | Amounts Reclassified from Accumulated Other Comprehensive Income | Affected Line Item in the Statement of Operations | ||||||||
Three Months Ended March 31, | ||||||||||
2016 | 2015 | |||||||||
Amortization of defined benefit pension items: | ||||||||||
Prior-service costs | $ | (0.2 | ) | $ | — | $(0.3) has been recorded within Cost of sales for the three months ended March 31, 2016 and $0.1 has been recorded within Selling, general & administrative for the three months ended March 31, 2016. | ||||
Net loss | 2.9 | 3.1 | $3.9 and $4.2 has been recorded within Cost of sales for the three months ended March 31, 2016 and 2015, respectively, and $(1.0) and $(1.1) has been recorded within Selling, general & administrative for the three months ended March 31, 2016 and 2015, respectively | |||||||
Amortization of other postretirement items: | ||||||||||
Prior-service costs | (0.1 | ) | (0.1 | ) | Recorded within Selling, General & Administrative | |||||
Net gain | (0.1 | ) | (0.1 | ) | Recorded within Selling, General & Administrative | |||||
$ | 2.5 | $ | 2.9 | Total before tax | ||||||
0.7 | 1.0 | Tax benefit | ||||||||
Total reclassifications for the period | $ | 1.8 | $ | 1.9 | Net of tax |
(in millions) | Three Months Ended March 31, 2016 | Year Ended December 31, 2015 | |||||
Balance at beginning of period | $ | 1,167.9 | $ | 1,193.3 | |||
Currency translation and other | 10.4 | (23.4 | ) | ||||
Balance at end of period | $ | 1,178.3 | $ | 1,167.9 |
(in millions) | Three Months Ended March 31, 2016 | Year Ended December 31, 2015 | |||||
Balance at beginning of period, net of accumulated amortization | $ | 317.1 | $ | 353.5 | |||
Amortization expense | (7.7 | ) | (31.5 | ) | |||
Currency translation and other | 4.9 | (4.9 | ) | ||||
Balance at end of period, net of accumulated amortization | $ | 314.3 | $ | 317.1 |
Weighted Average Amortization Period of Finite Lived Assets (in years) | |||||||||||||||||||||||||
March 31, 2016 | December 31, 2015 | ||||||||||||||||||||||||
(in millions) | Gross Asset | Accumulated Amortization | Net | Gross Asset | Accumulated Amortization | Net | |||||||||||||||||||
Intellectual property rights | 16.5 | $ | 89.0 | $ | 51.9 | $ | 37.1 | $ | 88.3 | $ | 51.4 | $ | 36.9 | ||||||||||||
Customer relationships and backlog | 15.6 | 401.3 | 140.3 | 261.0 | 395.7 | 132.9 | 262.8 | ||||||||||||||||||
Drawings | 37.9 | 11.1 | 10.1 | 1.0 | 11.1 | 10.1 | 1.0 | ||||||||||||||||||
Other | 12.8 | 61.9 | 46.7 | 15.2 | 61.8 | 45.4 | 16.4 | ||||||||||||||||||
Total | 15.9 | $ | 563.3 | $ | 249.0 | $ | 314.3 | $ | 556.9 | $ | 239.8 | $ | 317.1 |
(in millions) | March 31, 2016 | December 31, 2015 | |||||
Employee related expenses | $ | 70.9 | $ | 83.1 | |||
Warranty | 15.8 | 15.1 | |||||
Advanced payment from customers | 34.3 | 29.1 | |||||
Other | 92.5 | 91.3 | |||||
Total | $ | 213.5 | $ | 218.6 |
(in millions) | Three Months Ended March 31, 2016 | Year Ended December 31, 2015 | |||||
Balance at beginning of period | $ | 15.1 | $ | 15.5 | |||
Expense | 3.6 | 12.1 | |||||
Payments / deductions | (2.7 | ) | (12.7 | ) | |||
Currency translation | (0.2 | ) | 0.2 | ||||
Balance at end of period | $ | 15.8 | $ | 15.1 |
Three Months Ended | Year Ended | |||||||
March 31, | December 31, | |||||||
2016 | 2015 | 2015 | ||||||
Beginning claims | 41,090 | 47,507 | 47,507 | |||||
New claims | 980 | 633 | 2,572 | |||||
Settlements | (394 | ) | (208 | ) | (954 | ) | ||
Dismissals | (1,027 | ) | (3,345 | ) | (8,035 | ) | ||
Ending claims | 40,649 | 44,587 | 41,090 |
Three Months Ended | Year Ended | ||||||||||
(in millions) | March 31, | December 31, | |||||||||
2016 | 2015 | 2015 | |||||||||
Settlement / indemnity costs incurred (1) | $ | 11.3 | $ | 7.8 | $ | 27.7 | |||||
Defense costs incurred (1) | 10.0 | 10.5 | 41.7 | ||||||||
Total costs incurred | $ | 21.3 | $ | 18.3 | $ | 69.4 | |||||
Settlement / indemnity payments | $ | 5.1 | $ | 5.5 | $ | 24.5 | |||||
Defense payments | 8.6 | 8.1 | 43.5 | ||||||||
Insurance receipts | (2.9 | ) | (2.9 | ) | (18.1 | ) | |||||
Pre-tax cash payments | $ | 10.8 | $ | 10.7 | $ | 49.9 |
(1) | Before insurance recoveries and tax effects. |
Pension Benefits | |||||||
Three Months Ended March 31, | |||||||
(in millions) | 2016 | 2015 | |||||
Service cost | $ | 1.2 | $ | 1.4 | |||
Interest cost | 8.2 | 9.6 | |||||
Expected return on plan assets | (14.5 | ) | (15.6 | ) | |||
Amortization of prior service cost | (0.2 | ) | — | ||||
Amortization of net loss (gain) | 2.9 | 3.1 | |||||
Net periodic cost | $ | (2.4 | ) | $ | (1.5 | ) |
2016 | 2015 | |
Three months ended March 31, | 27.9% | 32.7% |
• | The favorable impact the 2016 Japanese tax reform had on the valuation of the Company’s Japanese deferred tax balances, |
• | Inclusion of the U.S. federal research credit, which had expired on December 31, 2014 and was not renewed with retroactive effect until December 2015, |
• | A greater U.S. federal tax benefit on domestic manufacturing activities, and |
• | The unfavorable impact the 2015 Japanese tax reform had on certain of the Company’s Japanese tax carryforwards. |
(in millions) | March 31, 2016 | December 31, 2015 | |||||
Long-term debt consists of: | |||||||
2.75% notes due 2018 | |||||||
Principal amount | $ | 250.0 | $ | 250.0 | |||
Less debt issuance costs (See Note 1) | (1.1 | ) | (1.2 | ) | |||
Carrying Value | $ | 248.9 | $ | 248.8 | |||
4.45% notes due 2023 | |||||||
Principal amount | $ | 300.0 | $ | 300.0 | |||
Less debt issuance costs (See Note 1) | (2.0 | ) | (2.1 | ) | |||
Carrying Value | $ | 298.0 | $ | 297.9 | |||
6.55% notes due 2036 | |||||||
Principal Amount | $ | 200.0 | $ | 200.0 | |||
Less unamortized discount | (0.7 | ) | (0.7 | ) | |||
Less debt issuance costs (See Note 1) | (1.4 | ) | (1.4 | ) | |||
Carrying Value | $ | 197.9 | $ | 197.9 | |||
Total long-term debt | $ | 744.8 | $ | 744.6 | |||
Short-term borrowings consists of: | |||||||
Commercial paper | $ | 77.5 | $ | 49.0 | |||
Other | 0.6 | 0.6 | |||||
Total short-term borrowings | $ | 78.1 | $ | 49.6 |
March 31, 2016 | December 31, 2015 | ||||||||||||||||||||||||||||||
Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | ||||||||||||||||||||||||||
(in millions) | Level 1 | Level 2 | Level 3 | Total Fair Value | Level 1 | Level 2 | Level 3 | Total Fair Value | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||
Derivatives - foreign exchange contracts | $ | — | $ | 0.5 | $ | — | $ | 0.5 | $ | — | $ | — | $ | — | $ | — | |||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||
Derivatives - foreign exchange contracts | $ | — | $ | 0.3 | $ | — | $ | 0.3 | $ | — | $ | 0.4 | $ | — | $ | 0.4 |
(in millions) | (Gains)/Costs Incurred in 2016 | Total Costs Incurred Through March 31, 2016 | ||||
2015 Repositioning Actions | — | 8.6 | ||||
Acquisition-Related Restructuring | (0.4 | ) | 9.3 | |||
Total Restructuring | $ | (0.4 | ) | $ | 17.9 |
(in millions) | Costs Incurred in 2016 | Total Costs Incurred Through March 31, 2016 | ||||
Fluid Handling | ||||||
Severance | $ | — | $ | 7.9 | ||
Aerospace & Electronics | ||||||
Severance | — | 0.7 | ||||
Total Restructuring | $ | — | $ | 8.6 |
(in millions) | Balance at December 31, 2015 | Expense | Utilization | Balance at March 31, 2016 | |||||||||||
Fluid Handling | |||||||||||||||
Severance | $ | 4.1 | $ | — | $ | (0.6 | ) | $ | 3.5 | ||||||
Aerospace & Electronics | |||||||||||||||
Severance | 0.1 | $ | — | — | 0.1 | ||||||||||
Total Restructuring | $ | 4.2 | $ | — | $ | (0.6 | ) | $ | 3.6 |
(in millions) | Costs (Gains) Incurred in 2016 | Total Costs Incurred Through March 31, 2016 | ||||
Payment & Merchandising Technologies | ||||||
Severance | $ | (0.4 | ) | $ | 13.4 | |
Other | — | 0.2 | ||||
Asset write-down | — | 0.1 | ||||
Pension curtailment gain | — | (4.4 | ) | |||
Total Restructuring | $ | (0.4 | ) | $ | 9.3 |
(in millions) | Balance at December 31, 2015 | Expense | Utilization | Balance at March 31, 2016 | |||||||||
Payment & Merchandising Technologies | |||||||||||||
Severance | $ | 6.3 | (0.4 | ) | (1.2 | ) | $ | 4.7 | |||||
Total Restructuring | $ | 6.3 | (0.4 | ) | (1.2 | ) | $ | 4.7 |
Year-to-Date | Change | ||||||||||||
(dollars in millions) | 2016 | 2015 | $ | % | |||||||||
Net sales | $ | 660.0 | $ | 678.8 | (18.8 | ) | (2.8 | )% | |||||
Restructuring and related charges | (0.4 | ) | 2.7 | (3.1 | ) | (114.8 | )% | ||||||
Acquisition integration related charges | — | 1.6 | (1.6 | ) | (100.0 | )% | |||||||
Operating profit | 85.5 | 86.0 | (0.5 | ) | (0.6 | )% | |||||||
Operating margin | 13.0 | % | 12.7 | % | |||||||||
Other income (expense): | |||||||||||||
Interest income | 0.5 | 0.5 | — | — | % | ||||||||
Interest expense | (9.1 | ) | (9.9 | ) | 0.8 | 8.1 | % | ||||||
Miscellaneous - net | (0.3 | ) | (0.3 | ) | — | — | % | ||||||
(8.9 | ) | (9.7 | ) | 0.8 | 8.2 | % | |||||||
Income before income taxes | 76.6 | 76.3 | 0.3 | 0.4 | % | ||||||||
Provision for income taxes | 21.4 | 24.9 | (3.5 | ) | (14.1 | )% | |||||||
Net income before allocation to noncontrolling interests | 55.2 | 51.3 | 3.9 | 7.6 | % | ||||||||
Less: Noncontrolling interest in subsidiaries’ earnings | 0.2 | 0.3 | (0.1 | ) | (33.3 | )% | |||||||
Net income attributable to common shareholders | 55.0 | 51.1 | 3.9 | 7.6 | % |
• | a decline in core sales of $5.5 million, or 0.8%; and |
• | unfavorable foreign currency translation of $13.3 million, or 2.0%. |
• | The favorable impact the 2016 Japanese tax reform had on the valuation of our Japanese deferred tax balances, |
• | Inclusion of the U.S. federal research credit, which had expired on December 31, 2014 and was not renewed with retroactive effect until December 2015, |
• | A greater U.S. federal tax benefit on domestic manufacturing activities, and |
• | The unfavorable impact the 2015 Japanese tax reform had on certain of our Japanese tax carryforwards. |
Three Months Ended | |||||||
March 31, | |||||||
2016 | 2015 | ||||||
Net income before allocation to noncontrolling interests | $ | 55.2 | $ | 51.3 | |||
Other comprehensive income (loss), net of tax | |||||||
Currency translation adjustment | 31.8 | (70.9 | ) | ||||
Changes in pension and postretirement plan assets and benefit obligation, net of tax | 1.9 | 2.0 | |||||
Other comprehensive income (loss) | 33.7 | (68.9 | ) | ||||
Comprehensive income before allocation to noncontrolling interests | 88.9 | (17.6 | ) | ||||
Less: Noncontrolling interests in comprehensive income (loss) | 0.3 | 0.1 | |||||
Comprehensive income (loss) attributable to common shareholders | $ | 88.6 | $ | (17.7 | ) |
Year-To-Date | Change | |||||||||||||
(dollars in millions) | 2016 | 2015 | $ | % | ||||||||||
Net sales by product line: | ||||||||||||||
Process Valves and Related Products | $ | 155.0 | $ | 175.7 | $ | (20.7 | ) | (11.8 | )% | |||||
Commercial Valves | 72.4 | 79.6 | (7.2 | ) | (9.0 | )% | ||||||||
Other Products | 20.6 | 20.2 | 0.4 | 2.0 | % | |||||||||
Total net sales | 248.0 | 275.5 | (27.5 | ) | (10.0 | )% | ||||||||
Operating profit | 25.4 | 34.3 | (8.9 | ) | (25.9 | )% | ||||||||
Restructuring and related charges* | — | 1.8 | (1.8 | ) | (100.0 | )% | ||||||||
Operating margin | 10.3 | % | 12.6 | % | ||||||||||
* Restructuring and related charges are included in operating profit and operating margin. |
• | Sales of Process Valves and Related Products decreased by $20.7 million, or 11.8%, to $155.0 million in 2016, including a core sales decline of $17.5 million, or 10.0%, and unfavorable foreign currency translation of $3.2 million, or 1.8%, as both the euro and British pound weakened against the U.S. dollar. The decrease in core sales reflected depressed oil prices driving lower capital spending by our customers and continued economic weakness in Asia. |
• | Sales of Commercial Valves decreased by $7.2 million, or 9.0%, to $72.4 million in 2016, reflecting unfavorable foreign currency translation of $6.0 million, or 7.7%, as the Canadian dollar and British pound weakened against the U.S. dollar. Core sales decreased $1.2 million, or 1.3%, reflecting lower sales in non-residential construction in the UK, partially offset by higher sales to non-residential construction markets in Canada. |
Year-To-Date | Change | |||||||||||||
(dollars in millions) | 2016 | 2015 | $ | % | ||||||||||
Net sales by product line: | ||||||||||||||
Payment Acceptance and Dispensing Products | $ | 117.7 | $ | 123.9 | $ | (6.2 | ) | (5.0 | )% | |||||
Merchandising Equipment | 54.3 | 48.0 | 6.3 | 13.1 | % | |||||||||
Total net sales | 172.0 | 171.9 | 0.1 | 0.1 | % | |||||||||
Operating profit | 28.0 | 21.1 | 6.9 | 32.7 | % | |||||||||
Acquisition, integration and restructuring related charges* | (0.4 | ) | 1.8 | (2.2 | ) | (122.2 | )% | |||||||
Operating margin | 16.3 | % | 12.3 | % | ||||||||||
* The acquisition, integration and restructuring related charges are included in operating profit and operating margin. |
• | Sales of Payment Acceptance and Dispensing Products decreased $6.2 million, or 5.0%, to $117.7 million in 2016, reflecting unfavorable foreign currency translation of $2.7 million, or 2.2%, and a core sales decrease of $3.5 million, or 2.8%. Unfavorable foreign currency translation reflected the British pound, Swiss franc and Australian dollar weakening against the U.S. dollar. The decrease in core sales reflected challenging year-over-year comparisons, including timing related to certain project orders. |
• | Sales of Merchandising Equipment increased $6.3 million, or 13.1%, to $54.3 million in 2016, reflecting a core sales increase of $7.0 million, or 14.6%, partially offset by unfavorable foreign currency translation of $0.7 million, or 1.5%. The increase in core sales was primarily related to stronger bottler sales during the first quarter of 2016. |
Year-To-Date | Change | |||||||||||||
(dollars in millions) | 2016 | 2015 | $ | % | ||||||||||
Net sales by product line: | ||||||||||||||
Commercial Original Equipment | $ | 90.0 | $ | 86.5 | $ | 3.5 | 4.0 | % | ||||||
Military Original Equipment | 40.6 | 33.1 | 7.5 | 22.7 | % | |||||||||
Commercial Aftermarket | 30.4 | 31.7 | (1.3 | ) | (4.1 | )% | ||||||||
Military Aftermarket | 10.7 | 10.3 | 0.4 | 3.9 | % | |||||||||
Total net sales | 171.7 | 161.6 | 10.1 | 6.3 | % | |||||||||
Operating profit | 33.1 | 30.1 | 3.0 | 10.0 | % | |||||||||
Restructuring and related charges* | — | 0.9 | (0.9 | ) | (100.0 | )% | ||||||||
Operating margin | 19.3 | % | 18.6 | % | ||||||||||
* Restructuring and related charges are included in operating profit and operating margin. |
• | Sales of Commercial Original Equipment increased by $3.5 million, or 4.0%, to $90.0 million in 2016. The sales increase was driven by strength from space and large transport markets, partially offset by weaker business jet related sales. |
• | Sales of Military Original Equipment increased by $7.5 million, or 22.7%, to $40.6 million in 2016. The sales increase primarily reflected shipments related to a large military program. |
Year-To-Date | Change | |||||||||||||
(dollars in millions) | 2016 | 2015 | $ | % | ||||||||||
Net sales by product line: | ||||||||||||||
FRP- Recreational Vehicles | $ | 35.2 | $ | 38.9 | $ | (3.7 | ) | (9.5 | )% | |||||
FRP- Building Products | 22.5 | 21.2 | 1.3 | 6.1 | % | |||||||||
FRP- Transportation | 10.6 | 9.6 | 1.0 | 10.4 | % | |||||||||
Total net sales | 68.3 | 69.7 | (1.4 | ) | (2.0 | )% | ||||||||
Operating profit | 13.7 | 14.3 | (0.6 | ) | (4.2 | )% | ||||||||
Operating margin | 20.1 | % | 20.5 | % |
Exhibit 10.1 | Crane Co. Annual Incentive Plan (2016 Amendment and Restatement) (incorporated by reference to Exhibit A to the Company's Proxy Statement filed on March 14, 2016) | |
Exhibit 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) | |
Exhibit 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) | |
Exhibit 32.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(b) or 15d-14(b) | |
Exhibit 32.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(b) or 15d-14(b) | |
Exhibit 101.INS | XBRL Instance Document | |
Exhibit 101.SCH | XBRL Taxonomy Extension Schema Document | |
Exhibit 101.CAL | XBRL Taxonomy Calculation Linkbase Document | |
Exhibit 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
Exhibit 101.LAB | XBRL Taxonomy Label Linkbase Document | |
Exhibit 101.PRE | XBRL Taxonomy Presentation Linkbase Document |
CRANE CO. | ||
REGISTRANT | ||
Date | ||
May 5, 2016 | By | /s/ Max H. Mitchell |
Max H. Mitchell | ||
President and Chief Executive Officer | ||
Date | By | /s/ Richard A. Maue |
May 5, 2016 | Richard A. Maue | |
Vice President, Finance and | ||
Chief Financial Officer |
Exhibit No. | Description | |
Exhibit 10.1 | Crane Co. Annual Incentive Plan (2016 Amendment and Restatement) (incorporated by reference to Exhibit A to the Company's Proxy Statement filed on March 14, 2016) | |
Exhibit 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) | |
Exhibit 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) | |
Exhibit 32.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(b) or 15d-14(b) | |
Exhibit 32.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(b) or 15d-14(b) | |
Exhibit 101.INS | XBRL Instance Document | |
Exhibit 101.SCH | XBRL Taxonomy Extension Schema Document | |
Exhibit 101.CAL | XBRL Taxonomy Calculation Linkbase Document | |
Exhibit 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
Exhibit 101.LAB | XBRL Taxonomy Label Linkbase Document | |
Exhibit 101.PRE | XBRL Taxonomy Presentation Linkbase Document |
(1) | I have reviewed this Quarterly Report on Form 10-Q of Crane Co.; |
(2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
(3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
(4) | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(5) | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
By /s/ Max H. Mitchell |
President and Chief Executive Officer |
May 5, 2016 |
(1) | I have reviewed this Quarterly Report on Form 10-Q of Crane Co.; |
(2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
(3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
(4) | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(5) | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
By /s/ Richard A. Maue |
Principal Financial Officer |
May 5, 2016 |
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
By /s/ Max H. Mitchell |
Max H. Mitchell |
President and Chief Executive Officer |
May 5, 2016 |
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
By Richard A. Maue |
Richard A. Maue |
Principal Financial Officer |
May 5, 2016 |
Document and Entity Information - shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Apr. 30, 2016 |
|
Entity Information [Line Items] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2016 | |
Document Fiscal Year Focus | 2016 | |
Document Fiscal Period Focus | Q1 | |
Trading Symbol | CR | |
Entity Registrant Name | Crane Co /DE/ | |
Entity Central Index Key | 0000025445 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 58,303,042 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Net income before allocation to noncontrolling interests | $ 55.2 | $ 51.3 |
Currency translation adjustment | 31.8 | (70.9) |
Changes in pension and postretirement plan assets and benefit obligation, net of tax benefit | 1.9 | 2.0 |
Other comprehensive income (loss) | 33.7 | (68.9) |
Comprehensive income before allocation to noncontrolling interests | 88.9 | (17.6) |
Less: Noncontrolling interests in comprehensive income (loss) | 0.3 | 0.1 |
Comprehensive income attributable to common shareholders | $ 88.6 | $ (17.7) |
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Preferred shares, par value | $ 0.01 | $ 0.01 |
Preferred shares, shares authorized | 5,000,000,000 | 5,000,000,000 |
Common stock, par value | $ 1.00 | $ 1.00 |
Common stock, shares authorized | 200,000,000,000 | 200,000,000,000 |
Common stock, shares issued | 72,426,139 | 72,426,139 |
Basis of Presentation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and, therefore, reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. All such adjustments are of a normal recurring nature. These interim condensed consolidated financial statements should be read in conjunction with the Consolidated Financial Statements and Notes to Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. Recent Accounting Pronouncements - Not Yet Adopted In March 2016, the Financial Accounting Standards Board ("FASB") issued amended guidance related to employee share-based payment accounting. The amended guidance simplifies several aspects related to the accounting for share-based payment transactions, including the accounting for income taxes, statutory tax withholding requirements, forfeitures and classification on the statement of cash flows. This amended guidance is effective for fiscal years, beginning after December 15, 2016, and interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating when to adopt the new standard, and the impact the amended guidance will have on its consolidated financial statements and related disclosures. In February 2016, the FASB issued amended guidance on accounting for leases. The amended guidance requires the recognition of a right-of-use asset and a lease liability for all leases by lessees with the exception of short-term leases and amends disclosure requirements associated with leasing arrangements. The new standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2018 using a modified retrospective transition approach. Early adoption is permitted. The Company is currently evaluating when to adopt the new standard, and the impact the amended guidance will have on its consolidated financial statements and related disclosures. In November 2015, the FASB issued amended guidance to simplify the presentation of deferred income taxes. The amendments require deferred tax liabilities and assets to be classified as noncurrent. The amended guidance is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted. The amended guidance will not have an impact on the Company’s results of operations or cash flows, but will affect the presentation of deferred income taxes on its consolidated financial position. In July 2015, the FASB issued amended guidance, which changes the measurement principle for inventory from the lower of cost or market to the lower of cost and net realizable value. The guidance defines net realizable value as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The new guidance must be applied on a prospective basis and is effective for fiscal years beginning after December 15, 2016, and interim periods within those years, with early adoption permitted. The Company does not expect the amended guidance to have a material impact on its consolidated financial statements. In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all current industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB agreed to a one-year deferral of the effective date; the new standard is now effective for reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Early adoption of the new revenue standard is permitted, however, entities reporting under U.S. GAAP are not permitted to adopt the standard earlier than the original effective date, December 15, 2016. The new standard can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company is currently evaluating when to adopt the new standard, the impacts of adoption and the implementation approach to be used. Recent Accounting Pronouncements - Adopted In April 2015, the FASB issued amended guidance to simplify the presentation of debt issuance costs. The amended guidance requires debt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The amendment is effective for periods beginning after December 15, 2015, with early adoption permitted. The Company adopted the provisions of this guidance in the first quarter of 2016 and applied it retrospectively to prior periods. The impact on the Company's consolidated financial statements is summarized below: Consolidated Balance Sheets as of December 31, 2015 (in millions):
In September 2015, the FASB issued amended guidance regarding business combinations that requires an acquirer to recognize post-close measurement adjustments for provisional amounts in the period the adjustment amounts are determined rather than retrospectively. The acquirer is also required to recognize, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the provisional amount, calculated as if the accounting had been completed at the acquisition date. The updated guidance is to be applied prospectively effective for annual and interim periods beginning after December 15, 2015. The Company adopted the guidance in the first quarter of 2016 and will apply it prospectively. The adoption of the guidance did not have an impact on its consolidated financial statements. |
Segment Results |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Results | Segment Results The Company’s segments are reported on the same basis used internally for evaluating performance and for allocating resources. The Company has four reportable segments: Fluid Handling, Payment & Merchandising Technologies, Aerospace & Electronics and Engineered Materials. Assets of the reportable segments exclude general corporate assets, which principally consist of cash, deferred tax assets, insurance receivables, certain property, plant and equipment, and certain other assets. Furthermore, Corporate consists of corporate office expenses including compensation, benefits, occupancy, depreciation, and other administrative costs.
The table below presents net sales by product line for each segment:
|
Earnings Per Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | Earnings Per Share The Company’s basic earnings per share calculations are based on the weighted average number of common shares outstanding during the period. Shares of restricted stock are included in the computation of both basic and diluted earnings per share. Potentially dilutive securities include outstanding stock options, restricted share units, deferred stock units and performance-based restricted share units. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury method. Diluted earnings per share gives effect to all potentially dilutive common shares outstanding during the period.
The computation of diluted earnings per share excludes the effect of the potential exercise of stock options when the average market price of the common stock is lower than the exercise price of the related stock options during the period (1.5 million and 0.8 million average options were excluded for the first quarter of 2016 and 2015, respectively). |
Changes in Equity and Comprehensive Income |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes in Equity and Comprehensive Income | Changes in Equity and Accumulated Other Comprehensive Income A summary of the changes in equity for the three months ended March 31, 2016 and 2015 is provided below:
The table below provides the accumulated balances for each classification of accumulated other comprehensive income (loss), as reflected on the Condensed Consolidated Balance Sheets.
* Net of tax benefit of $109.1 million and $109.8 million for March 31, 2016 and December 31, 2015, respectively. The table below illustrates the amounts reclassified out of each component of accumulated other comprehensive income for the three month periods ended March 31, 2016 and 2015.
|
Acquisitions |
3 Months Ended |
---|---|
Mar. 31, 2016 | |
Business Combinations [Abstract] | |
Acquisitions | Acquisitions On December 11, 2013, the Company completed the acquisition of MEI Conlux Holdings (U.S.), Inc. and its affiliate MEI Conlux Holdings (Japan), Inc. (together, "MEI"), a leading provider of payment solutions for unattended transaction systems, serving customers in the transportation, gaming, retail, financial services and vending markets. The purchase price was $804 million for all of the outstanding equity interests of MEI. MEI has been integrated into the Company's Crane Payment Innovations business within its Payment & Merchandising Technologies segment. Acquisition-Related Costs Acquisition-related costs were expensed as incurred. For the quarter ended March 31, 2015, the Company recorded $1.6 million of acquisition integration related charges and $0.2 million of restructuring costs. See additional discussion in Note 14. |
Goodwill and Intangible Assets |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets | Goodwill and Intangible Assets The Company’s business acquisitions have typically resulted in the recognition of goodwill and other intangible assets. The Company follows the provisions of ASC Topic 350, “Intangibles – Goodwill and Other” (“ASC 350”) as it relates to the accounting for goodwill in the Condensed Consolidated Financial Statements. These provisions require that the Company, on at least an annual basis, evaluate the fair value of the reporting units to which goodwill is assigned and attributed and compare that fair value to the carrying value of the reporting unit to determine if an impairment has occurred. The Company performs its annual impairment testing during the fourth quarter. Impairment testing takes place more often than annually if events or circumstances indicate a change in status that would indicate a potential impairment. The Company believes that there have been no events or circumstances which would more likely than not reduce the fair value for its reporting units below its carrying value. A reporting unit is an operating segment unless discrete financial information is prepared and reviewed by segment management for businesses one level below that operating segment (a “component”), in which case the component would be the reporting unit. In certain instances, the Company has aggregated components of an operating segment into a single reporting unit based on similar economic characteristics. At March 31, 2016, the Company had seven reporting units. When performing its annual impairment assessment, the Company compares the fair value of each of its reporting units to its respective carrying value. Goodwill is considered to be potentially impaired when the net book value of the reporting unit exceeds its estimated fair value. Fair values are established primarily by discounting estimated future cash flows at an estimated cost of capital which varies for each reporting unit and which, as of the Company’s most recent annual impairment assessment, ranged between 10.0% and 12.5% (a weighted average of 10.8%), reflecting the respective inherent business risk of each of the reporting units tested. This methodology for valuing the Company’s reporting units (commonly referred to as the Income Method) has not changed since the adoption of the provisions under ASC 350. The determination of discounted cash flows is based on the businesses’ strategic plans and long-range planning forecasts, which change from year to year. The revenue growth rates included in the forecasts represent best estimates based on current and forecasted market conditions. Profit margin assumptions are projected by each reporting unit based on the current cost structure and anticipated net cost increases/reductions. There are inherent uncertainties related to these assumptions, including changes in market conditions, and management judgment is necessary in applying them to the analysis of goodwill impairment. In addition to the foregoing, for each reporting unit, market multiples are used to corroborate its discounted cash flow results where fair value is estimated based on earnings multiples determined by available public information of comparable businesses. While the Company believes it has made reasonable estimates and assumptions to calculate the fair value of its reporting units, it is possible a material change could occur. If actual results are not consistent with management’s estimates and assumptions, goodwill and other intangible assets may then be determined to be overstated and a charge would need to be taken against net earnings. Furthermore, in order to evaluate the sensitivity of the fair value calculations on the goodwill impairment test performed during the fourth quarter of 2015, the Company applied a hypothetical, reasonably possible 10% decrease to the fair values of each reporting unit. The effects of this hypothetical 10% decrease would still result in the fair value calculation exceeding the carrying value for each reporting unit. Changes to goodwill are as follows:
Changes to intangible assets are as follows:
As of March 31, 2016, the Company had $314.3 million of net intangible assets, of which $27.8 million were intangibles with indefinite useful lives, consisting of trade names. The Company amortizes the cost of other intangibles over their estimated useful lives unless such lives are deemed indefinite. Intangibles with indefinite useful lives are tested annually for impairment, or when events or changes in circumstances indicate the potential for impairment. If the carrying amount of an intangible asset with an indefinite useful life exceeds the fair value, the intangible asset is written down to its fair value. Fair value is calculated using discounted cash flows. In addition to annual testing for impairment of indefinite-lived intangible assets, the Company reviews all of its long-lived assets, including intangible assets subject to amortization, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Examples of events or changes in circumstances could include, but are not limited to, a prolonged economic downturn, current period operating or cash flow losses combined with a history of losses or a forecast of continuing losses associated with the use of an asset or asset group, or a current expectation that an asset or asset group will be sold or disposed of before the end of its previously estimated useful life. Recoverability is based upon projections of anticipated future undiscounted cash flows associated with the use and eventual disposal of the long-lived asset (or asset group), as well as specific appraisal in certain instances. Reviews occur at the lowest level for which identifiable cash flows are largely independent of cash flows associated with other long-lived assets or asset groups and include estimated future revenues, gross profit margins, operating profit margins and capital expenditures which are based on the businesses’ strategic plans and long-range planning forecasts, which change from year to year. The revenue growth rates included in the forecasts represent our best estimates based on current and forecasted market conditions, and the profit margin assumptions are based on the current cost structure and anticipated net cost increases/reductions. There are inherent uncertainties related to these assumptions, including changes in market conditions, and management’s judgment in applying them to the analysis. If the future undiscounted cash flows are less than the carrying value, then the long-lived asset is considered impaired and a charge would be taken against net earnings based on the amount by which the carrying amount exceeds the estimated fair value. Judgments that the Company makes which impact these assessments relate to the expected useful lives of long-lived assets and its ability to realize any undiscounted cash flows in excess of the carrying amounts of such assets, and are affected primarily by changes in the expected use of the assets, changes in technology or development of alternative assets, changes in economic conditions, changes in operating performance and changes in expected future cash flows. Since judgment is involved in determining the fair value of long-lived assets, there is risk that the carrying value of our long-lived assets may require adjustment in future periods. Historical results to date have generally approximated expected cash flows for the identifiable cash flow generating level. The Company believes that there have been no events or circumstances which would more likely than not reduce the fair value of its indefinite-lived and amortizing intangible assets. A summary of intangible assets follows:
Amortization expense for these intangible assets is currently estimated to be approximately $23.2 million in total for the remainder of 2016, $29.9 million in 2017, $26.9 million in 2018, $24.3 million in 2019, $21.6 million in 2020 and $160.6 million in 2021 and thereafter. |
Accrued Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payables and Accruals [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued Liabilities | Accrued Liabilities Accrued liabilities consist of:
The Company accrues warranty liabilities when it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. Warranty provision is included in Cost of sales in the Condensed Consolidated Statements of Operations. A summary of the warranty liabilities is as follows:
|
Commitments and Contingencies |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | Commitments and Contingencies Asbestos Liability Information Regarding Claims and Costs in the Tort System As of March 31, 2016, the Company was a defendant in cases filed in numerous state and federal courts alleging injury or death as a result of exposure to asbestos. Activity related to asbestos claims during the periods indicated was as follows:
Of the 40,649 pending claims as of March 31, 2016, approximately 18,400 claims were pending in New York, approximately 4,800 claims were pending in Texas, approximately 5,100 claims were pending in Mississippi, and approximately 200 claims were pending in Ohio, all jurisdictions in which legislation or judicial orders restrict the types of claims that can proceed to trial on the merits. The Company has tried several cases resulting in defense verdicts by the jury or directed verdicts for the defense by the court. The Company further has pursued appeals of certain adverse jury verdicts that have resulted in reversals in favor of the defense. On March 23, 2010, a Philadelphia, Pennsylvania, state court jury found the Company responsible for a 1/11th share of a $14.5 million verdict in the James Nelson claim, and for a 1/20th share of a $3.5 million verdict in the Larry Bell claim. On February 23, 2011, the court entered judgment on the verdicts in the amount of $0.2 million against the Company, only, in Bell, and in the amount of $4.0 million, jointly, against the Company and two other defendants in Nelson, with additional interest in the amount of $0.01 million being assessed against the Company, only, in Nelson. All defendants, including the Company, and the plaintiffs took timely appeals of certain aspects of those judgments. The Company resolved the Bell appeal by settlement, which is reflected in the settled claims for 2012. On September 5, 2013, a panel of the Pennsylvania Superior Court, in a 2-1 decision, vacated the Nelson verdict against all defendants, reversing and remanding for a new trial. Plaintiffs requested a rehearing in the Superior Court and by order dated November 18, 2013, the Superior Court vacated the panel opinion, and granted en banc reargument. On December 23, 2014, the Superior Court issued a second opinion reversing the jury verdict. Plaintiffs sought leave to appeal to the Pennsylvania Supreme Court, which defendants have opposed. By order dated May 20, 2015, the Supreme Court of Pennsylvania is holding, but not acting on, the plaintiffs' petition pending the outcome of another appeal in which the Company is not a party. On August 17, 2011, a New York City state court jury found the Company responsible for a 99% share of a $32 million verdict on the Ronald Dummitt claim. The Company filed post-trial motions seeking to overturn the verdict, to grant a new trial, or to reduce the damages, which the Company argued were excessive under New York appellate case law governing awards for non-economic losses. The Court held oral argument on these motions on October 18, 2011 and issued a written decision on August 21, 2012 confirming the jury's liability findings but reducing the award of damages to $8 million. At plaintiffs' request, the Court entered a judgment in the amount of $4.9 million against the Company, taking into account settlement offsets and accrued interest under New York law. The Company appealed, and the judgment was affirmed in a 3-2 decision and order dated July 3, 2014. The Company has appealed to the New York Court of Appeals. The parties' briefing has concluded and the court heard oral arguments on May 3, 2016. On October 23, 2012, the Company received an adverse verdict in the Gerald Suttner claim in Buffalo, New York. The jury found that the Company was responsible for four percent (4%) of plaintiffs' damages of $3 million. The Company filed post-trial motions requesting judgment in the Company's favor notwithstanding the jury's verdict, which were denied. The court entered a judgment of $0.1 million against the Company. The Company appealed, and the judgment was affirmed by order dated March 21, 2014. The Company sought reargument of this decision, which was denied. The Company sought review before the New York Court of Appeals, which was accepted in the fourth quarter of 2014. The parties' briefing has concluded and the court heard oral arguments on May 3, 2016. On November 28, 2012, the Company received an adverse verdict in the James Hellam claim in Oakland, CA. The jury found that the Company was responsible for seven percent (7%) of plaintiffs' non-economic damages of $4.5 million, plus a portion of their economic damages of $0.9 million. Based on California court rules regarding allocation of damages, judgment was entered against the Company in the amount of $1.282 million. The Company filed post-trial motions requesting judgment in the Company's favor notwithstanding the jury's verdict and also requesting that settlement offsets be applied to reduce the judgment in accordance with California law. On January 31, 2013, the court entered an order disposing partially of that motion. On March 1, 2013, the Company filed an appeal regarding the portions of the motion that were denied. The court entered judgment against the Company in the amount of $1.1 million. The Company appealed. By opinion dated April 16, 2014, the Court of Appeal affirmed the finding of liability against the Company, and the California Supreme Court denied review of this ruling. The Court of Appeal reserved the arguments relating to recoverable damages to a subsequent appeal that remains pending. On August 21, 2015, the Court of Appeal reversed the trial court with respect to a $20,000 damages item, but affirmed the trial court in all other respects. The Company sought review of that ruling before the Supreme Court of California, which was denied. The Company settled the matter in December 2015. The settlement is reflected in the fourth quarter 2015 indemnity amount. On February 25, 2013, a Philadelphia, Pennsylvania, state court jury found the Company responsible for a 1/10th share of a $2.5 million verdict in the Thomas Amato claim and a 1/5th share of a $2.3 million verdict in the Frank Vinciguerra claim, which were consolidated for trial. The Company filed post-trial motions requesting judgments in the Company's favor notwithstanding the jury's verdicts or new trials, and also requesting that settlement offsets be applied to reduce the judgment in accordance with Pennsylvania law. These motions were denied. The Company has appealed, and on April 17, 2015, a panel of the Superior Court of Pennsylvania affirmed the trial court's ruling. The Supreme Court of Pennsylvania has accepted the Company’s petition for review, and that appeal remains pending. On March 1, 2013, a New York City state court jury entered a $35 million verdict against the Company in the Ivo Peraica claim. The Company filed post-trial motions seeking to overturn the verdict, to grant a new trial, or to reduce the damages, which the Company argues were excessive under New York appellate case law governing awards for non-economic losses and further were subject to settlement offsets. After the trial court remitted the verdict to $18 million, but otherwise denied the Company’s post-trial motion, judgment was entered against the Company in the amount of $10.6 million (including interest). The Company has appealed. The Company has taken a separate appeal of the trial court’s denial of its summary judgment motion. The Court has consolidated the appeals, which were heard in the fourth quarter of 2014. On July 31, 2013, a Buffalo, New York state court jury entered a $3.1 million verdict against the Company in the Lee Holdsworth claim. The Company filed post-trial motions seeking to overturn the verdict, to grant a new trial, or to reduce the damages, which the Company argues were excessive under New York appellate case law governing awards for non-economic losses and further were subject to settlement offsets. Post-trial motions were denied, and the court entered judgment in the amount of $1.7 million. On June 12, 2015, the Appellate Division, Fourth Department, affirmed the trial court's ruling denying the Company's motion for summary judgment. The court denied reargument of that ruling. The Company is pursuing a further appeal of the trial court rulings and judgment, which will be argued on May 16, 2016. On September 11, 2013, a Columbia, South Carolina state court jury in the Lloyd Garvin claim entered an $11 million verdict for compensatory damages against the Company and two other defendants jointly, and also awarded exemplary damages against the Company in the amount of $11 million. The jury also awarded exemplary damages against both other defendants. The Company filed post-trial motions seeking to overturn the verdict, which were denied, except that the Court remitted the compensatory damages award to $2.5 million and exemplary damages award to $3.5 million. Considering settlement offsets, the Court further reduced the total damages award to $3.5 million. The Company has settled the matter. The settlement is reflected in the first quarter 2015 indemnity amount. On September 17, 2013, a Fort Lauderdale, Florida state court jury in the Richard DeLisle claim found the Company responsible for 16 percent of an $8 million verdict. The trial court denied all parties’ post-trial motions, and entered judgment against the Company in the amount of $1.3 million. The Company has appealed. Oral argument on the appeal took place on February 16, 2016. On June 16, 2014, a New York City state court jury entered a $15 million verdict against the Company in the Ivan Sweberg claim and a $10 million verdict against the Company in the Selwyn Hackshaw claim. The two claims were consolidated for trial. The Company filed post-trial motions seeking to overturn the verdicts, to grant new trials, or to reduce the damages, which were denied, except that the Court reduced the Sweberg award to $10 million, and reduced the Hackshaw award to $6 million. Judgments have been entered in the amount of $5.3 million in Sweberg and $3.1 million in Hackshaw. The Company has appealed. Oral argument on Sweberg took place on February 16, 2016, and oral argument on Hackshaw took place on March 9, 2016. On July 2, 2015, a St. Louis, Missouri state court jury in the James Poage claim entered a $1.5 million verdict for compensatory damages against the Company. The jury also awarded exemplary damages against the Company in the amount of $10 million. The Company filed a motion seeking to reduce the verdict to account for the verdict set-offs. That motion was denied, and judgment was entered against the Company in the amount of $10.8 million. The Company is pursuing an appeal. On February 9, 2016, a Philadelphia, Pennsylvania, federal court jury found the Company responsible for a 30 percent share of a $1.085 million verdict in the Valent Rabovsky claim. The court has ordered briefing on the amount of the judgment. The Company will argue, among other things, that settlement offsets reduce the award to plaintiff under Pennsylvania law. A further hearing is scheduled for April 26, 2016, and it is anticipated that the court will enter judgment on the verdict after that argument. The Company will pursue post-trial relief and an appeal if necessary. On April 22, 2016, a Phoenix, Arizona federal court jury found the Company responsible for a 20 percent share of a $9 million verdict in the George Coulbourn claim, and further awarded exemplary damages against the Company in the amount of $5 million. The jury also awarded compensatory and exemplary damages against the other defendant present at trial. The Company will pursue post-trial relief and an appeal if necessary. Such judgment amounts are not included in the Company’s incurred costs until all available appeals are exhausted and the final payment amount is determined. The gross settlement and defense costs incurred (before insurance recoveries and tax effects) for the Company for the three-month periods ended March 31, 2016 and 2015 totaled $21.3 million and $18.3 million, respectively. In contrast to the recognition of settlement and defense costs, which reflect the current level of activity in the tort system, cash payments and receipts generally lag the tort system activity by several months or more, and may show some fluctuation from quarter to quarter. Cash payments of settlement amounts are not made until all releases and other required documentation are received by the Company, and reimbursements of both settlement amounts and defense costs by insurers may be uneven due to insurer payment practices, transitions from one insurance layer to the next excess layer and the payment terms of certain reimbursement agreements. The Company’s total pre-tax payments for settlement and defense costs, net of funds received from insurers, for the three-month periods ended March 31, 2016 and 2015 totaled $10.8 million and $10.7 million, respectively. Detailed below are the comparable amounts for the periods indicated.
The amounts shown for settlement and defense costs incurred, and cash payments, are not necessarily indicative of future period amounts, which may be higher or lower than those reported. Cumulatively through March 31, 2016, the Company has resolved (by settlement or dismissal) approximately 117,000 claims. The related settlement cost incurred by the Company and its insurance carriers is approximately $464 million, for an average settlement cost per resolved claim of approximately $4,000. The average settlement cost per claim resolved during the years ended December 31, 2015, 2014 and 2013 was $3,100, $3,800 and $3,300, respectively. Because claims are sometimes dismissed in large groups, the average cost per resolved claim, as well as the number of open claims, can fluctuate significantly from period to period. In addition to large group dismissals, the nature of the disease and corresponding settlement amounts for each claim resolved will also drive changes from period to period in the average settlement cost per claim. Accordingly, the average cost per resolved claim is not considered in the Company’s periodic review of its estimated asbestos liability. For a discussion regarding the four most significant factors affecting the liability estimate, see “Effects on the Condensed Consolidated Financial Statements”. Effects on the Condensed Consolidated Financial Statements The Company has retained the firm of Hamilton, Rabinovitz & Associates, Inc. (“HR&A”), a nationally recognized expert in the field, to assist management in estimating the Company’s asbestos liability in the tort system. HR&A reviews information provided by the Company concerning claims filed, settled and dismissed, amounts paid in settlements and relevant claim information such as the nature of the asbestos-related disease asserted by the claimant, the jurisdiction where filed and the time lag from filing to disposition of the claim. The methodology used by HR&A to project future asbestos costs is based largely on the Company’s experience during a base reference period of eleven quarterly periods (consisting of the two full preceding calendar years and three additional quarterly periods to the estimate date) for claims filed, settled and dismissed. The Company's experience is then compared to estimates of the number of individuals likely to develop asbestos-related diseases determined based on widely used previously conducted epidemiological studies augmented with current data inputs. Those studies were undertaken in connection with national analyses of the population of workers believed to have been exposed to asbestos. Using that information, HR&A estimates the number of future claims that would be filed against the Company and estimates the aggregate settlement or indemnity costs that would be incurred to resolve both pending and future claims based upon the average settlement costs by disease during the reference period. This methodology has been accepted by numerous courts. After discussions with the Company, HR&A augments its liability estimate for the costs of defending asbestos claims in the tort system using a forecast from the Company which is based upon discussions with its defense counsel. Based on this information, HR&A compiles an estimate of the Company’s asbestos liability for pending and future claims, based on claim experience during the reference period and covering claims expected to be filed through the indicated forecast period. The most significant factors affecting the liability estimate are (1) the number of new mesothelioma claims filed against the Company, (2) the average settlement costs for mesothelioma claims, (3) the percentage of mesothelioma claims dismissed against the Company and (4) the aggregate defense costs incurred by the Company. These factors are interdependent, and no one factor predominates in determining the liability estimate. Although the methodology used by HR&A can be applied to show claims and costs for periods subsequent to the indicated period (up to and including the endpoint of the asbestos studies referred to above), management believes that the level of uncertainty regarding the various factors used in estimating future asbestos costs is too great to provide for reasonable estimation of the number of future claims, the nature of such claims or the cost to resolve them for years beyond the indicated estimate. In the Company’s view, the forecast period used to provide the best estimate for asbestos claims and related liabilities and costs is a judgment based upon a number of trend factors, including the number and type of claims being filed each year; the jurisdictions where such claims are filed, and the effect of any legislation or judicial orders in such jurisdictions restricting the types of claims that can proceed to trial on the merits; and the likelihood of any comprehensive asbestos legislation at the federal level. In addition, the dynamics of asbestos litigation in the tort system have been significantly affected over the past five to ten years by the substantial number of companies that have filed for bankruptcy protection, thereby staying any asbestos claims against them until the conclusion of such proceedings, and the establishment of a number of post-bankruptcy trusts for asbestos claimants, which are estimated to provide $36 billion for payments to current and future claimants. These trend factors have both positive and negative effects on the dynamics of asbestos litigation in the tort system and the related best estimate of the Company’s asbestos liability, and these effects do not move in a linear fashion but rather change over multi-year periods. Accordingly, the Company’s management continues to monitor these trend factors over time and periodically assesses whether an alternative forecast period is appropriate. Each quarter, HR&A compiles an update based upon the Company’s experience in claims filed, settled and dismissed during the updated reference period (consisting of the preceding eleven quarterly periods) as well as average settlement costs by disease category (mesothelioma, lung cancer, other cancer, and non-malignant conditions including asbestosis) during that period. In addition to this claims experience, the Company also considers additional quantitative and qualitative factors such as the nature of the aging of pending claims, significant appellate rulings and legislative developments, and their respective effects on expected future settlement values. As part of this process, the Company also takes into account trends in the tort system such as those enumerated above. Management considers all these factors in conjunction with the liability estimate of HR&A and determines whether a change in the estimate is warranted. Liability Estimate. With the assistance of HR&A, effective as of December 31, 2011, the Company updated and extended its estimate of the asbestos liability, including the costs of settlement or indemnity payments and defense costs relating to currently pending claims and future claims projected to be filed against the Company through 2021. The Company’s previous estimate was for asbestos claims filed or projected to be filed through 2017. As a result of this updated estimate, the Company recorded an additional liability of $285 million as of December 31, 2011. The Company’s decision to take this action at such date was based on several factors which contribute to the Company’s ability to reasonably estimate this liability for the additional period noted. First, the number of mesothelioma claims (which although constituting approximately 8% of the Company’s total pending asbestos claims, have accounted for approximately 90% of the Company’s aggregate settlement and defense costs) being filed against the Company and associated settlement costs have recently stabilized. In the Company’s opinion, the outlook for mesothelioma claims expected to be filed and resolved in the forecast period is reasonably stable. Second, there have been favorable developments in the trend of case law which has been a contributing factor in stabilizing the asbestos claims activity and related settlement costs. Third, there have been significant actions taken by certain state legislatures and courts over the past several years that have reduced the number and types of claims that can proceed to trial, which has been a significant factor in stabilizing the asbestos claims activity. Fourth, the Company has now entered into coverage-in-place agreements with almost all of its excess insurers, which enables the Company to project a more stable relationship between settlement and defense costs paid by the Company and reimbursements from its insurers. Taking all of these factors into account, the Company believes that it can reasonably estimate the asbestos liability for pending claims and future claims to be filed through 2021. While it is probable that the Company will incur additional charges for asbestos liabilities and defense costs in excess of the amounts currently provided, the Company does not believe that any such amount can be reasonably estimated beyond 2021. Accordingly, no accrual has been recorded for any costs which may be incurred for claims which may be made subsequent to 2021. Management has made its best estimate of the costs through 2021 based on the analysis by HR&A completed in January 2012. Through March 31, 2016, the Company’s actual experience during the updated reference period for mesothelioma claims filed and dismissed generally approximated the assumptions in the Company’s liability estimate. In addition to this claims experience, the Company considered additional quantitative and qualitative factors such as the nature of the aging of pending claims, significant appellate rulings and legislative developments, and their respective effects on expected future settlement values. Based on this evaluation, the Company determined that no change in the estimate was warranted for the period ended March 31, 2016. Nevertheless, if certain factors show a pattern of sustained increase or decrease, the liability could change materially; however, all the assumptions used in estimating the asbestos liability are interdependent and no single factor predominates in determining the liability estimate. As noted above, the Company continues to monitor trend factors, such as the number and type of claims being filed each year, case management orders and legislation restricting the types of claims that can proceed to trial, significant appellate rulings and developments affecting the post-bankruptcy trusts for asbestos claimants to assess whether the existing forecast period is appropriate. Because of the uncertainty with regard to and the interdependency of such factors used in the calculation of its asbestos liability, and since no one factor predominates, the Company believes that a range of potential liability estimates beyond the indicated forecast period cannot be reasonably estimated. A liability of $894 million was recorded as of December 31, 2011 to cover the estimated cost of asbestos claims now pending or subsequently asserted through 2021, of which approximately 80% is attributable to settlement and defense costs for future claims projected to be filed through 2021. The liability is reduced when cash payments are made in respect of settled claims and defense costs. The liability was $532 million as of March 31, 2016. It is not possible to forecast when cash payments related to the asbestos liability will be fully expended; however, it is expected such cash payments will continue for a number of years past 2021, due to the significant proportion of future claims included in the estimated asbestos liability and the lag time between the date a claim is filed and when it is resolved. None of these estimated costs have been discounted to present value due to the inability to reliably forecast the timing of payments. The current portion of the total estimated liability at March 31, 2016 was $75 million and represents the Company’s best estimate of total asbestos costs expected to be paid during the twelve-month period. Such amount is based upon the HR&A model together with the Company’s prior year payment experience for both settlement and defense costs. Insurance Coverage and Receivables. Prior to 2005, a significant portion of the Company’s settlement and defense costs were paid by its primary insurers. With the exhaustion of that primary coverage, the Company began negotiations with its excess insurers to reimburse the Company for a portion of its settlement and/or defense costs as incurred. To date, the Company has entered into agreements providing for such reimbursements, known as “coverage-in-place”, with eleven of its excess insurer groups. Under such coverage-in-place agreements, an insurer’s policies remain in force and the insurer undertakes to provide coverage for the Company’s present and future asbestos claims on specified terms and conditions that address, among other things, the share of asbestos claims costs to be paid by the insurer, payment terms, claims handling procedures and the expiration of the insurer’s obligations. Similarly, under a variant of coverage-in-place, the Company has entered into an agreement with a group of insurers confirming the aggregate amount of available coverage under the subject policies and setting forth a schedule for future reimbursement payments to the Company based on aggregate indemnity and defense payments made. In addition, with ten of its excess insurer groups, the Company entered into policy buyout agreements, settling all asbestos and other coverage obligations for an agreed sum, totaling $82.5 million in aggregate. Reimbursements from insurers for past and ongoing settlement and defense costs allocable to their policies have been made in accordance with these coverage-in-place and other agreements. All of these agreements include provisions for mutual releases, indemnification of the insurer and, for coverage-in-place, claims handling procedures. With the agreements referenced above, the Company has concluded settlements with all but one of its solvent excess insurers whose policies are expected to respond to the aggregate costs included in the updated liability estimate. That insurer, which issued a single applicable policy, has been paying the shares of defense and indemnity costs the Company has allocated to it, subject to a reservation of rights. There are no pending legal proceedings between the Company and any insurer contesting the Company’s asbestos claims under its insurance policies. In conjunction with developing the aggregate liability estimate referenced above, the Company also developed an estimate of probable insurance recoveries for its asbestos liabilities. In developing this estimate, the Company considered its coverage-in-place and other settlement agreements described above, as well as a number of additional factors. These additional factors include the financial viability of the insurance companies, the method by which losses will be allocated to the various insurance policies and the years covered by those policies, how settlement and defense costs will be covered by the insurance policies and interpretation of the effect on coverage of various policy terms and limits and their interrelationships. In addition, the timing and amount of reimbursements will vary because the Company’s insurance coverage for asbestos claims involves multiple insurers, with different policy terms and certain gaps in coverage. In addition to consulting with legal counsel on these insurance matters, the Company retained insurance consultants to assist management in the estimation of probable insurance recoveries based upon the aggregate liability estimate described above and assuming the continued viability of all solvent insurance carriers. Based upon the analysis of policy terms and other factors noted above by the Company’s legal counsel, and incorporating risk mitigation judgments by the Company where policy terms or other factors were not certain, the Company’s insurance consultants compiled a model indicating how the Company’s historical insurance policies would respond to varying levels of asbestos settlement and defense costs and the allocation of such costs between such insurers and the Company. Using the estimated liability as of December 31, 2011 (for claims filed or expected to be filed through 2021), the insurance consultant’s model forecasted that approximately 25% of the liability would be reimbursed by the Company’s insurers. While there are overall limits on the aggregate amount of insurance available to the Company with respect to asbestos claims, those overall limits were not reached by the total estimated liability currently recorded by the Company, and such overall limits did not influence the Company in its determination of the asset amount to record. The proportion of the asbestos liability that is allocated to certain insurance coverage years, however, exceeds the limits of available insurance in those years. The Company allocates to itself the amount of the asbestos liability (for claims filed or expected to be filed through 2021) that is in excess of available insurance coverage allocated to such years. An asset of $225 million was recorded as of December 31, 2011 representing the probable insurance reimbursement for such claims expected through 2021. The asset is reduced as reimbursements and other payments from insurers are received. The asset was $126 million as of March 31, 2016. The Company reviews the aforementioned estimated reimbursement rate with its insurance consultants on a periodic basis in order to confirm its overall consistency with the Company’s established reserves. The reviews encompass consideration of the performance of the insurers under coverage-in-place agreements and the effect of any additional lump-sum payments under policy buyout agreements. Since December 2011, there have been no developments that have caused the Company to change the estimated 25% rate, although actual insurance reimbursements vary from period to period, and will decline over time, for the reasons cited above. Uncertainties. Estimation of the Company’s ultimate exposure for asbestos-related claims is subject to significant uncertainties, as there are multiple variables that can affect the timing, severity and quantity of claims and the manner of their resolution. The Company cautions that its estimated liability is based on assumptions with respect to future claims, settlement and defense costs based on past experience that may not prove reliable as predictors. A significant upward or downward trend in the number of claims filed, depending on the nature of the alleged injury, the jurisdiction where filed and the quality of the product identification, or a significant upward or downward trend in the costs of defending claims, could change the estimated liability, as would substantial adverse verdicts at trial that withstand appeal. A legislative solution, structured settlement transaction, or significant change in relevant case law could also change the estimated liability. The same factors that affect developing estimates of probable settlement and defense costs for asbestos-related liabilities also affect estimates of the probable insurance reimbursements, as do a number of additional factors. These additional factors include the financial viability of the insurance companies, the method by which losses will be allocated to the various insurance policies and the years covered by those policies, how settlement and defense costs will be covered by the insurance policies and interpretation of the effect on coverage of various policy terms and limits and their interrelationships. In addition, due to the uncertainties inherent in litigation matters, no assurances can be given regarding the outcome of any litigation, if necessary, to enforce the Company’s rights under its insurance policies or settlement agreements. Many uncertainties exist surrounding asbestos litigation, and the Company will continue to evaluate its estimated asbestos-related liability and corresponding estimated insurance reimbursement as well as the underlying assumptions and process used to derive these amounts. These uncertainties may result in the Company incurring future charges or increases to income to adjust the carrying value of recorded liabilities and assets, particularly if the number of claims and settlement and defense costs change significantly, or if there are significant developments in the trend of case law or court procedures, or if legislation or another alternative solution is implemented; however, the Company is currently unable to estimate such future changes and, accordingly, while it is probable that the Company will incur additional charges for asbestos liabilities and defense costs in excess of the amounts currently provided, the Company does not believe that any such amount can be reasonably determined beyond 2021. Although the resolution of these claims may take many years, the effect on the results of operations, financial position and cash flow in any given period from a revision to these estimates could be material. |
Pension and Other Postretirement Benefit Plans |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pension and Other Postretirement Benefit Plans | Pension Benefits The components of net periodic cost are as follows:
The Company expects, based on current actuarial calculations, to contribute approximately $8.0 million to its defined benefit plans, of which $2.1 million has been contributed during the first three months of 2016. The Company contributed $17.0 million to its defined benefit plans in 2015. Cash contributions for subsequent years will depend on a number of factors, including the impact of the Pension Protection Act signed into law in 2006, changes in minimum funding requirements, long-term interest rates, the investment performance of plan assets and changes in employee census data affecting the Company’s projected benefit obligations. |
Income Taxes |
3 Months Ended | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||
Income Taxes | Income Taxes The Company’s quarterly provision for income taxes is measured using an annual effective tax rate, adjusted for discrete items within the periods presented. Effective Tax Rates The Company’s effective tax rates are as follows:
The Company’s effective tax rate for the three months ended March 31, 2016 is lower than the prior year’s comparable period primarily due to:
The Company's effective tax rate for the three months ended March 31, 2016 is lower than the statutory U.S. federal tax rate of 35% primarily due to the favorable impacts of income earned in jurisdictions with tax rates lower than the U.S. statutory rate, the U.S. federal tax benefit for domestic manufacturing activities and the U.S. federal research credit. These items are partially offset by the unfavorable impacts of U.S. state taxes and certain expenses that are statutorily non-deductible for income tax purposes. Unrecognized Tax Benefits During the three months ended March 31, 2016, the Company's gross unrecognized tax benefits, excluding interest and penalties, increased by $0.8 million primarily as a result of tax positions taken in both the current and prior periods. During the three months ended March 31, 2016, the total amount of unrecognized tax benefits that, if recognized, would affect the Company's effective tax rate increased by $0.9 million. The Company recognizes interest and penalties related to unrecognized tax benefits as a component of its income tax expense. During the three months ended March 31, 2016, the Company recognized $0.4 million of interest and penalty expense related to unrecognized tax benefits in its Condensed Consolidated Statement of Operations. At March 31, 2016 and December 31, 2015, the Company had accrued $6.2 million and $5.8 million, respectively, of interest and penalties related to unrecognized tax benefits in its Condensed Consolidated Balance Sheets. During the next twelve months, it is reasonably possible that the Company's unrecognized tax benefits may decrease by $7.1 million due to expiration of statutes of limitations and settlements with tax authorities. However, if the ultimate resolution of income tax examinations results in amounts that differ from this estimate, the Company will record additional income tax expense or benefit in the period in which such matters are effectively settled. Income Tax Examinations The Company's income tax returns are subject to examination by the U.S. federal, U.S. state and local, and non-U.S. tax authorities. The Company’s federal income tax returns for the years 2010 through 2012 are currently under examination by the U.S. Internal Revenue Service (IRS), and its federal income tax returns for 2013 and 2014 remain subject to examination. The IRS recently began an examination of an acquired subsidiary’s consolidated federal income tax return for 2013. In addition, acquired subsidiaries’ federal returns (2011 and 2012) and federal tax carry forwards (2006 through 2012) remain subject to IRS examination. With few exceptions, the Company is no longer subject to U.S. state and local or non-U.S. income tax examinations for years before 2010. Currently the Company and its subsidiaries are under examination in various jurisdictions, including Germany (2008 through 2012), Canada (2013 and 2014) and California (2010 and 2011). |
Long-Term Debt and Notes Payable |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-Term Debt and Notes Payable | Long-Term Debt and Short-Term Borrowings The following table summarizes the Company’s debt as of March 31, 2016 and December 31, 2015:
On March 2, 2015, the Company entered into a commercial paper program (the “CP Program”) pursuant to which it may issue short-term, unsecured commercial paper notes (the “Notes”) pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. Amounts available under the CP Program may be borrowed, repaid and re-borrowed from time to time, with the aggregate principal amount of the Notes outstanding under the CP Program at any time not to exceed $500 million. The Notes will have maturities of up to 397 days from date of issue. The Notes will rank at least on equal terms with all of our other unsecured and unsubordinated indebtedness. The net proceeds of the issuances of the Notes were used to repay amounts under our revolving credit facility and for general corporate purposes. At March 31, 2016, Notes with a principal amount of $77.5 million were outstanding. |
Derivative Instruments and Hedging Activities |
3 Months Ended |
---|---|
Mar. 31, 2016 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments and Hedging Activities | Derivative Instruments and Hedging Activities The Company is exposed to certain risks related to its ongoing business operations, including market risks related to fluctuation in currency exchange. The Company uses foreign exchange contracts to manage the risk of certain cross-currency business relationships to minimize the impact of currency exchange fluctuations on the Company’s earnings and cash flows. The Company does not hold or issue derivative financial instruments for trading or speculative purposes. As of and for the period ended March 31, 2016, the foreign exchange contracts designated as hedging instruments did not have a material impact on the Company’s condensed consolidated statements of operations, balance sheet or cash flows. Foreign exchange contracts not designated as hedging instruments, which primarily pertain to foreign exchange fluctuation risk of intercompany positions, had a notional value of $26 million and $38 million as of March 31, 2016 and December 31, 2015, respectively. The settlement of derivative contracts for the three months March 31, 2015 resulted in net cash outflow $12.0 million, respectively, and is reported within other in “Total used for operating activities” on the Condensed Consolidated Statements of Cash Flows. As of March 31, 2016 and December 31, 2015, the Company's receivable position for the foreign exchange contracts was $0.5 million and $0 million, respectively. As of March 31, 2016 and December 31, 2015, the Company's payable position for the foreign exchange contracts was $0.3 million and $0.4 million, respectively. |
Fair Value Measurements |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements | Fair Value Measurements Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are to be considered from the perspective of a market participant that holds the asset or owes the liability. The standards also establish a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standards describe three levels of inputs that may be used to measure fair value: Level 1: Quoted prices in active markets for identical or similar assets and liabilities. Level 2: Quoted prices for identical or similar assets and liabilities in markets that are not active or observable inputs other than quoted prices in active markets for identical or similar assets and liabilities. Level 2 assets and liabilities include over-the-counter derivatives, principally forward foreign exchange contracts, whose value is determined using pricing models with inputs that are generally based on published foreign exchange rates and exchange traded prices, adjusted for other specific inputs that are primarily observable in the market or can be derived principally from or corroborated by observable market data. Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The following table summarizes assets and liabilities measured at fair value on a recurring basis at the dates indicated:
Valuation Technique - The Company’s derivative assets and liabilities include foreign exchange contract derivatives that are measured at fair value using internal models based on observable market inputs such as forward rates and interest rates. Based on these inputs, the derivatives are classified within Level 2 of the valuation hierarchy. The carrying value of the Company’s financial assets and liabilities, including cash and cash equivalents, accounts receivable, accounts payable and short-term loans payable approximate fair value, without being discounted, due to the short periods during which these amounts are outstanding. Long-term debt rates currently available to the Company for debt with similar terms and remaining maturities are used to estimate the fair value for debt issues that are not quoted on an exchange. The estimated fair value of long-term debt is measured using Level 2 inputs and was $804.9 million and $791.1 million at March 31, 2016 and December 31, 2015, respectively. |
Restructuring |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring | Restructuring The following table summarizes the restructuring (gains) costs associated with repositioning and acquisition-related actions noted below:
2015 Repositioning Actions The Company initiated incremental restructuring activities and recorded pre-tax restructuring charges of $8.6 million in 2015. The Company expects these actions to result in workforce reductions of approximately 125 employees, or about 1%, of the Company’s global workforce. The following table summarizes the restructuring charges by cost type and segment:
The following table summarizes the accrual balances related to these cash-related restructuring charges:
The Company does not expect any further significant costs associated with these actions. Acquisition-Related Restructuring The Company recorded total pre-tax restructuring charges of $9.3 million (a gain of $0.4 million in 2016, a gain of $0.6 million in 2015 and a charge of $10.3 million in 2014) related to the December 2013 acquisition of MEI within the Company's Payment & Merchandising Technologies segment. The Company expects these actions to result in workforce reductions of approximately 240 employees, or less than 2% of the Company’s global workforce. The following table summarizes the restructuring charges by cost type and segment:
The following table summarizes the accrual balances related to these cash-related restructuring charges:
The Company does not expect any further significant costs associated with these actions. |
Segment Results (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Financial Information By Reportable Segment |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Assets By Segment |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Goodwill By Segment |
|
Earnings Per Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Computation of Basic and Diluted Earnings per Share |
|
Changes in Equity and Comprehensive Income (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary Of Changes In Equity | A summary of the changes in equity for the three months ended March 31, 2016 and 2015 is provided below:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Classification Of Accumulated Other Comprehensive Income Reflected On Consolidated Balance Sheets | The table below provides the accumulated balances for each classification of accumulated other comprehensive income (loss), as reflected on the Condensed Consolidated Balance Sheets.
* Net of tax benefit of $109.1 million and $109.8 million for March 31, 2016 and December 31, 2015, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amounts Reclassified out of each Component of AOCI | The table below illustrates the amounts reclassified out of each component of accumulated other comprehensive income for the three month periods ended March 31, 2016 and 2015.
|
Goodwill and Intangible Assets (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes To Goodwill | Changes to goodwill are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes To Intangible Assets | Changes to intangible assets are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary Of Intangible Assets | A summary of intangible assets follows:
|
Accrued Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payables and Accruals [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Accrued Liabilities | Accrued liabilities consist of:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary Of Warranty Liabilities | A summary of the warranty liabilities is as follows:
|
Commitments and Contingencies (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Activity Related To Asbestos Claims | Activity related to asbestos claims during the periods indicated was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Settlement And Defense Costs | Detailed below are the comparable amounts for the periods indicated.
|
Pension and Other Postretirement Benefit Plans (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components Of Net Periodic Cost | he components of net periodic cost are as follows:
|
Income Taxes Income Taxes (Tables) |
3 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||
Schedule of Effective Income Tax Rate Reconciliation | The Company’s effective tax rates are as follows:
|
Long-Term Debt and Notes Payable (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components Of Debt | The following table summarizes the Company’s debt as of March 31, 2016 and December 31, 2015:
|
Fair Value Measurements (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary Of Assets And Liabilities Measured At Fair Value On A Recurring Basis | The following table summarizes assets and liabilities measured at fair value on a recurring basis at the dates indicated:
|
Restructuring Restructuring (Tables) |
3 Months Ended |
---|---|
Mar. 31, 2016 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Restructuring Reserve by Type of Cost [Table Text Block] | |
Schedule of Restructuring and Related Costs [Table Text Block] |
Basis of Presentation Recently adopted accounting pronouncement (Details) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Other Assets, Noncurrent | $ 106.1 | $ 101.3 |
Assets | 3,395.0 | 3,336.9 |
Long-term debt | 744.8 | 744.6 |
Liabilities and Equity | $ 3,395.0 | 3,336.9 |
Scenario, Previously Reported [Member] | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Other Assets, Noncurrent | 106.0 | |
Assets | 3,341.6 | |
Long-term debt | 749.3 | |
Liabilities and Equity | 3,341.6 | |
Adjustments for New Accounting Pronouncement [Member] | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Other Assets, Noncurrent | (4.7) | |
Assets | (4.7) | |
Long-term debt | (4.7) | |
Liabilities and Equity | $ (4.7) |
Segment Results (Narrative) (Detail) |
3 Months Ended |
---|---|
Mar. 31, 2016
Segment
| |
Segment Reporting [Abstract] | |
Number of reportable segments | 4 |
Segment Results (Schedule Of Assets By Segment) (Detail) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Segment Reporting, Asset Reconciling Item [Line Items] | ||
Assets | $ 3,395.0 | $ 3,336.9 |
Fluid Handling [Member] | ||
Segment Reporting, Asset Reconciling Item [Line Items] | ||
Assets | 907.7 | 888.0 |
Payment and Merchandising Technologies [Member] | ||
Segment Reporting, Asset Reconciling Item [Line Items] | ||
Assets | 1,213.8 | 1,178.0 |
Aerospace and Electronics [Member] | ||
Segment Reporting, Asset Reconciling Item [Line Items] | ||
Assets | 569.4 | 559.4 |
Engineered Materials | ||
Segment Reporting, Asset Reconciling Item [Line Items] | ||
Assets | 234.0 | 227.6 |
Corporate | ||
Segment Reporting, Asset Reconciling Item [Line Items] | ||
Assets | $ 470.1 | $ 483.9 |
Segment Results (Schedule Of Goodwill By Segment) (Detail) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
---|---|---|---|
Segment Reporting Information [Line Items] | |||
Goodwill | $ 1,178.3 | $ 1,167.9 | $ 1,193.3 |
Fluid Handling [Member] | |||
Segment Reporting Information [Line Items] | |||
Goodwill | 221.0 | 218.7 | |
Payment and Merchandising Technologies [Member] | |||
Segment Reporting Information [Line Items] | |||
Goodwill | 583.4 | 575.2 | |
Aerospace and Electronics [Member] | |||
Segment Reporting Information [Line Items] | |||
Goodwill | 202.5 | 202.6 | |
Engineered Materials | |||
Segment Reporting Information [Line Items] | |||
Goodwill | $ 171.4 | $ 171.4 |
Earnings Per Share (Computation Of Basic And Diluted Earnings Per Share) (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Earnings Per Share [Abstract] | ||
Net income attributable to common shareholders | $ 55.0 | $ 51.1 |
Average basic shares outstanding | 58.2 | 58.1 |
Effect of dilutive stock options | 0.7 | 0.8 |
Average diluted shares outstanding | 58.9 | 58.9 |
Earnings per share - basic: | ||
Net income attributable to common shareholders | $ 0.95 | $ 0.88 |
Earnings per share - diluted: | ||
Net income attributable to common shareholders | $ 0.93 | $ 0.87 |
Earnings Per Share (Narrative) (Detail) - shares shares in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Earnings Per Share [Abstract] | ||
Average options excluded from computation of diluted earnings per share | 1.5 | 0.8 |
Acquisitions (Narrative) (Detail) - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|
Dec. 31, 2013 |
Mar. 31, 2016 |
Mar. 31, 2015 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Business Acquisition [Line Items] | |||||
Business Combination, Integration Related Costs | $ 0.0 | $ 1.6 | |||
Restructuring Charges | $ (0.4) | $ 0.5 | |||
MEI Conlux Holdings [Member] | |||||
Business Acquisition [Line Items] | |||||
Business Combination, Consideration Transferred | $ 804.0 | ||||
2.75% Notes Due 2018 | |||||
Business Acquisition [Line Items] | |||||
Debt Instrument, Interest Rate, Stated Percentage | 2.75% | 2.75% | |||
Acquisition Related Restructuring [Member] | |||||
Business Acquisition [Line Items] | |||||
Restructuring Charges | $ (0.4) | $ (0.6) | $ 10.3 |
Goodwill and Intangible Assets (Narrative) (Detail) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2016
USD ($)
Segment
|
Dec. 31, 2015
USD ($)
|
|
Goodwill And Intangible Assets [Line Items] | ||
Number of reporting units | Segment | 7 | |
Estimated cost of capital, minimum | 10.00% | |
Estimated cost of capital, maximum | 12.50% | |
Estimated cost of capital, weighted | 10.80% | |
Hypothetical decrease to fair values of each reporting unit | 10.00% | |
Net intangible assets | $ 314.3 | $ 317.1 |
Intangibles with indefinite useful lives | 27.8 | |
Estimated amortization expense for intangible assets, current year | 23.2 | |
Estimated amortization expense for intangible assets, year 2015 | 29.9 | |
Estimated amortization expense for intangible assets, year 2016 | 26.9 | |
Estimated amortization expense for intangible assets, year 2017 | 24.3 | |
Estimated amortization expense for intangible assets, year 2018 | 21.6 | |
Estimated amortization expense for intangible assets, year 2019 and thereafter | $ 160.6 |
Goodwill And Intangible Assets (Changes To Goodwill) (Detail) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2016 |
Dec. 31, 2015 |
|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Balance at beginning of period | $ 1,167.9 | $ 1,193.3 |
Currency translation and other | 10.4 | (23.4) |
Balance at end of period | $ 1,178.3 | $ 1,167.9 |
Goodwill And Intangible Assets (Changes To Intangible Assets) (Detail) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2016 |
Dec. 31, 2015 |
|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Balance at beginning of period, net of accumulated amortization | $ 317.1 | $ 353.5 |
Amortization expense | (7.7) | (31.5) |
Currency translation and other | (4.9) | 4.9 |
Balance at end of period, net of accumulated amortization | $ 314.3 | $ 317.1 |
Accrued Liabilities (Schedule Of Accrued Liabilities) (Detail) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Payables and Accruals [Abstract] | ||
Employee related expenses | $ 70.9 | $ 83.1 |
Warranty | 15.8 | 15.1 |
Customer Advances, Current | 34.3 | 29.1 |
Other | 92.5 | 91.3 |
Total | $ 213.5 | $ 218.6 |
Accrued Liabilities (Summary Of Warranty Liabilities) (Detail) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2016 |
Dec. 31, 2015 |
|
Payables and Accruals [Abstract] | ||
Balance at beginning of period | $ 15.1 | $ 15.5 |
Expense | 3.6 | 12.1 |
Payments / deductions | (2.7) | (12.7) |
Currency translation | (0.2) | 0.2 |
Balance at end of period | $ 15.8 | $ 15.1 |
Commitments And Contingencies (Schedule Of Activity Related To Asbestos Claim) (Detail) $ in Millions |
3 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
Dec. 31, 2015 |
Dec. 31, 2014 |
Sep. 30, 2014
USD ($)
|
|
Loss Contingencies [Line Items] | |||||
Airplane Operating Lease Period Years | five | ||||
Fair Value Of Residual Value Guarantee | $ 7.8 | ||||
Fair Value Of Residual Value Guarantee, Fair Value of Operating Lease Asset Threshold | $ 9.5 | ||||
Asbestos Commitments and Contingencies | |||||
Loss Contingencies [Line Items] | |||||
Beginning claims | 41,090 | 47,507 | 47,507 | ||
New claims | 980 | 633 | 2,572 | ||
Settlements | (394) | (208) | (954) | ||
Dismissals | (1,027) | (3,345) | (8,035) | ||
Ending claims | 40,649 | 44,587 | 41,090 | 47,507 |
Commitments And Contingencies (Schedule Of Settlement And Defense Costs) (Detail) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
Dec. 31, 2015 |
|
Loss Contingencies [Line Items] | |||
Pre-tax cash payments | $ 10.8 | $ 10.7 | |
Asbestos Commitments and Contingencies | |||
Loss Contingencies [Line Items] | |||
Settlement / indemnity costs incurred (1) | 11.3 | 7.8 | $ 27.7 |
Defense costs incurred (1) | 10.0 | 10.5 | 41.7 |
Gross Settlement And Defense Incurred Costs | 21.3 | 18.3 | 69.4 |
Settlement / indemnity payments | 5.1 | 5.5 | 24.5 |
Defense payments | 8.6 | 8.1 | 43.5 |
Insurance receipts | (2.9) | (2.9) | (18.1) |
Pre-tax cash payments | $ 10.8 | $ 10.7 | $ 49.9 |
Pension And Other Postretirement Benefit Plans (Components Of Net Periodic Cost) (Detail) - Pension Plans, Defined Benefit - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | $ 1.2 | $ 1.4 |
Interest cost | 8.2 | 9.6 |
Expected return on plan assets | (14.5) | (15.6) |
Defined Benefit Plan, Amortization of Prior Service Cost (Credit) | (0.2) | 0.0 |
Amortization of net loss (gain) | 2.9 | 3.1 |
Net periodic cost | $ (2.4) | $ (1.5) |
Pension And Other Postretirement Benefit Plans (Narrative) (Detail) - Pension Plans, Defined Benefit - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2016 |
Dec. 31, 2016 |
Dec. 31, 2015 |
|
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Contributions by Employer | $ 2.1 | $ 17.0 | |
Subsequent Event [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plans, Estimated Future Employer Contributions in Next Fiscal Year | $ 8.0 |
Income Taxes (Narrative) (Detail) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
Dec. 31, 2015 |
|
Income Tax Disclosure [Abstract] | |||
Company's effective tax rate | 27.90% | 32.70% | |
Federal statutory income tax rate | 35.00% | ||
Increase in gross unrecognized tax benefits | $ 0.8 | ||
Increase In Unrecognized Tax Benefits That Would Impact Effective Tax Rate | 0.9 | ||
Recognized interest expense related to unrecognized tax benefits | 0.4 | ||
Interest and penalty related to unrecognized tax benefits recorded | 6.2 | $ 5.8 | |
Reasonable possible increase in unrecognized tax benefits during the next twelve months | $ (7.1) |
Derivative Instruments And Hedging Activities (Narrative) (Detail) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Dec. 31, 2015 |
|
Derivative Instruments, Gain (Loss) [Line Items] | ||
Notional value of foreign exchange contracts | $ 38.0 | |
Net cash outflow/inflow from settlement of derivative contracts | $ (12.0) | |
Derivatives Assets | 0.5 | 0.0 |
Derivatives Liabilities | 0.3 | $ 0.4 |
Foreign Exchange Contract [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Notional value of foreign exchange contracts | $ 26.0 |
Fair Value Measurements (Summary Of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivatives Assets | $ 0.5 | $ 0.0 |
Derivatives Liabilities | 0.3 | 0.4 |
Fair Value, Measurements, Recurring | Foreign Exchange Contract [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivatives Assets | 0.0 | |
Derivatives Liabilities | 0.4 | |
Fair Value, Measurements, Recurring | Foreign Exchange Contract [Member] | Fair Value, Inputs, Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivatives Assets | 0.5 | 0.0 |
Derivatives Liabilities | $ 0.3 | $ 0.4 |
Fair Value Measurements (Narrative) (Detail) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Fair Value Disclosures [Abstract] | ||
Estimated fair value of long-term debt | $ 804.9 | $ 791.1 |
Restructuring Restructuring 2014 Repositioning Actions (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Restructuring Cost and Reserve [Line Items] | ||
Restructuring Charges | $ (0.4) | $ 0.5 |
L7F1EJ_>H=K=0K=3X^[+^2Z6?.?TOI0L-#Q
M*W3\>MQQ(DSI);=L+@U;;(21T/<,^IX1@]^( #&4HP(X Y%"?487V.6)@;:,*LQQHK8&"H>&C"N=#E8]6U6>QN^8<.WVAACK(BU
M@0BM3L>0,+9!MH9*XMN+"6S%!-VX!T8Q@5T V010)X , 62ZC+O1Z#"UQMQ-
M;=*-QA@!9Y'=1CAA(S1FU99C%8YR_/!FR&ID#/)FH=U(-&$D,L;C@4 \,2/Q
M,S.23#A(#('(-B/+9%1F\F@1O$PD>3&2Q'8!M:,^K%-]_+Y0:-TT>A/0W!$2
MLU34[P@FZ,4&VCP$F6:LV\+5C+$O(.^!Q-1BA$^M1CBU'"'Z?B% ],1*V-RC
M(AMJ:Z"@-[OW[(Z.@8JPDSZQ.=C3 U1]C
M1/*;@UTLWMS)8VJ2ZM):-EJP82: 1
M=.'W"
8.K_,&$X$W8R
M87!\Y.,M%P]3O,7QB5H,4R,FR?$BL0ZH)D[-(!IO"\<[@8P30$Z\HK6DR0F@
M6L"JPG"J$JML"H7GO;B,%X>]:-:+0[48A1J,K8@BXL1GQM=C)X:/#YF6!!QO
MV98$9%)K742V*42E3&%Y+S'C)6(OP'J)J!:GA5[%(O!%XIVDC).$G;"5;!.J
M)!AAJF&15X6P?D
F\TP:J!EHW#O
M>GJ!>83;(%AK8>,7U:-U6EXH&$GVE5:NXCJE/WD^T[8)=";0A? CB\93HVCS
MB3E6E49/R*2M'5@XP=V>^HVHD8U%DZ;W1JVOGJO=/2W).0C-&!HQQRO,@B!>
M?6E!MUK,=+JBTVUZOD7/D\/\RF&^+5!L"11)H/C?B ESO,84_S0AJSV58+IX
M=2RJ]:CB15U5E]OY0..9?,.K8!4&\^M*";K68Z71%I]OT8HM>)(?%
ME<-/!'9; KLDL/MJQ(0Y7F.*#TW(:D\EF"Y>'8MJ/:IX45?5Y78^T'@F[_"J
M'%@'OYCIN++HI)T_V7@,K=8.O(GLYA:CWK^?)1'0NA!^\[%)5RHE3@^7![*\
MTNH_4$L#!!0 ( ,Z5I4@!AY*HHP$ +$# 9 >&PO=V]R:W-H965T
M
&UL?93+CILP%(9?!?$ #7B" U5*-V46DTBW;M
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M9&:Z9&5
R>^$(QK+^^4@SKKPG%L+[X1C"2]<4EQ;"^N*(8UA?7%,.N
M\W>*8=?YAF(,SPC%,D)MF:G(KDCTH-D>]+8''?-6[JV_V_)NBUEN,84OVA\.
M>$:!C@+)F P:DR'K8MDQF